hepatocellular carcinoma, liver metastases
Conditions
Interventions
Participants receive nine Hypersight CBCTs over three sessions.
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: • Written informed consent; • Patients discussed in multidisciplinary tumor board; • Patients diagnosed with liver metastases and referred to the dept. of Radiotherapy to undergo treatment with stereotactic radiotherapy; or patient >=65 years, diagnosed with HCC and referred to the dept. of Radiotherapy to undergo standard treatment; • Able to comply with breath-hold requirements.
Exclusion criteria
Exclusion criteria: Eligible for surgery, ablation or liver transplantation.Unable to undergo the planning MRI used in clinical workflow.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary parameters are inter- and intra-fraction fiducial position reproducibility on the Ethos. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary parameter is tumor position reproducibility using MRI fused with daily CBCT without making use of fiducials. | — |
Countries
Netherlands
Contacts
Public ContactA. Méndez Romero
Erasmus MC, Universitair Medisch Centrum Rotterdam
Outcome results
None listed